General Information of the Compound
Compound ID
CP0430263
Compound Name
5-bromanyl-4-(4-ethoxyphenoxy)-2-(4-propan-2-ylphenyl)pyridazin-3-one
    Show/Hide
Structure
Formula
C21H21BrN2O3
Molecular Weight
429.314
Canonical SMILES
CCOc1ccc(Oc2c(Br)cnn(-c3ccc(cc3)C(C)C)c2=O)cc1
    Show/Hide
InChI
InChI=1S/C21H21BrN2O3/c1-4-26-17-9-11-18(12-10-17)27-20-19(22)13-23-24(21(20)25)16-7-5-15(6-8-16)14(2)3/h5-14H,4H2,1-3H3
    Show/Hide
InChIKey
QKWJIBVIUGYPTI-UHFFFAOYSA-N
Physicochemical Property
logP
5.3094
Rotatable Bonds
6
Heavy Atom Count
27
Polar Areas
53.35
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Complexity
27

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 46172916
ChEMBL ID
CHEMBL1720787
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT06160, Neuropeptides B/W receptor type 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000025 HEK-293T Homo sapiens (Human)  1
1
IC50 = 720 nM
   TI
   LI
   LO
   TS